<code id='19364DDCAA'></code><style id='19364DDCAA'></style>
    • <acronym id='19364DDCAA'></acronym>
      <center id='19364DDCAA'><center id='19364DDCAA'><tfoot id='19364DDCAA'></tfoot></center><abbr id='19364DDCAA'><dir id='19364DDCAA'><tfoot id='19364DDCAA'></tfoot><noframes id='19364DDCAA'>

    • <optgroup id='19364DDCAA'><strike id='19364DDCAA'><sup id='19364DDCAA'></sup></strike><code id='19364DDCAA'></code></optgroup>
        1. <b id='19364DDCAA'><label id='19364DDCAA'><select id='19364DDCAA'><dt id='19364DDCAA'><span id='19364DDCAA'></span></dt></select></label></b><u id='19364DDCAA'></u>
          <i id='19364DDCAA'><strike id='19364DDCAA'><tt id='19364DDCAA'><pre id='19364DDCAA'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:3557
          Illustration of a person talking with a huge speech bubble over his head. -- health tech coverage from STAT
          Mike Reddy for STAT

          The health care sector is a notorious laggard when it comes to technology. It was slow to use computers, digitize patient data, and share information electronically. While most of the world instantly interacts via Zoom and Slack, hospitals — even today — are still sending faxes.

          But something different is happening with generative AI.

          advertisement

          Health systems, drugmakers, and insurers are racing to build the technology into their operations, aligning themselves with corporate giants such as Microsoft, Google, and Nvidia, whose executives speak about each incremental advancement of AI as an earth-shattering event. “The generative AI revolution is here,” Jensen Huang, 61, Nvidia’s leather-jacket-clad CEO, declared during the company’s GTC conference in San Jose, Calif., last week.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Gritstone Bio's cancer vaccine test, and more on Novartis' deal
          Gritstone Bio's cancer vaccine test, and more on Novartis' deal

          MollyFerguson/STATThisweek,IaddresspushbackIreceivedonmyNovartis-MorphoSyscolumn.Butfirst,apreviewof

          read more
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

          FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

          read more

          Why Novartis is going to walk from its acquisition of MorphoSys

          MollyFerguson/STATNovartissaidMondaythatitintendstobuyMorphoSysforjustunder$3billion.Thedealwillnotc